Whitton J L, Sheng N, Oldstone M B, McKee T A
Department of Neuropharmacology, Scripps Research Institute, La Jolla California 92037.
J Virol. 1993 Jan;67(1):348-52. doi: 10.1128/JVI.67.1.348-352.1993.
We have previously demonstrated that induction of antiviral cytotoxic T lymphocytes (CTL), in the absence of antiviral antibodies, can confer protection against a lethal-dose virus challenge. Here we extend those findings as follows. First, three discrete viral CTL epitopes expressed from minigenes encoding peptides as short as 12 amino acids can be recognized when expressed from recombinant vaccinia virus; second, concentrating on two of the three epitopes, we show that these vaccinia virus recombinants can confer protection in a major histocompatibility complex (MHC)-restricted manner; third, the minigenes can be fused to generate a "string of beads," and the close proximity of the two epitopes within one oligopeptide does not disrupt recognition of either epitope; fourth, this string-of-beads vaccine, in contrast to the single epitope vaccines, can protect on both MHC backgrounds; and, fifth, CTL to different epitopes may act synergistically, as protection is improved when the vaccine contains more than one CTL epitope for a given MHC background.
我们之前已经证明,在没有抗病毒抗体的情况下,诱导抗病毒细胞毒性T淋巴细胞(CTL)可以赋予针对致死剂量病毒攻击的保护作用。在此,我们将这些发现扩展如下。首先,当从重组痘苗病毒表达时,从编码短至12个氨基酸的肽的小基因表达的三个离散的病毒CTL表位可以被识别;其次,聚焦于这三个表位中的两个,我们表明这些痘苗病毒重组体可以以主要组织相容性复合体(MHC)限制的方式赋予保护作用;第三,小基因可以融合以产生“串珠”,并且一个寡肽内两个表位的紧密接近不会破坏对任何一个表位的识别;第四,与单个表位疫苗相比,这种串珠疫苗可以在两种MHC背景下提供保护;第五,针对不同表位的CTL可能协同作用,因为当疫苗对于给定的MHC背景包含多个CTL表位时,保护作用会增强。